Labyrinthin Vaccination in Veterans With Lung Adenocarcinoma
Labyrinthin Vaccination in Veterans With Lung Adenocarcinoma
Not yet recruiting · NCT07859592 · Registry updated 2026-10-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Labyrinthin Vaccination in Veterans With Lung Adenocarcinoma | Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, adenocarcinoma, autosomal recessive limb-girdle muscular dystrophy type 2C, carcinoma, epithelial neoplasm, neoplasm | Not yet recruiting | Phase 2 | 2026-10-06 | NCT07859592 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Kansas City VA Medical Center, Kansas City, MO | Kansas City | United States | 11 |
| San Francisco VA Medical Center, San Francisco, CA | San Francisco | United States | 19 |
| VA Long Beach Healthcare System, Long Beach, CA | Long Beach | United States | 22 |
| VA Northern California Health Care System, Mather, CA | Sacramento | United States | 6 |